+
+
Cyclization Vs Pd-H Elimination-Readdition
J. Am. Chem. Soc., Vol. 118, No. 30, 1996 7151
3.27 (d, 2H, J ) 6.5 Hz, H1), 2.82 (tt, 2H, J ) 7.5 Hz, 4JF-H ) 1.5 Hz,
H5), 2.42 (m, 2H, J ) 7.5 Hz, H4), 1.76 (q, 3H, J ) 1.3 Hz, Me3); MS
(EI) m/z (relative intensity), 416 (M+), 235 (81), 221 (27), 207 (48),
181 (100), 41 (21).
Separation of the η3-Allylpalladium Derivatives. Reaction of
[Pd(C6F5)Br(NCMe)2] with 1,4-Pentadiene. To a solution of
[Pd(C6F5)Br(NCMe)2] (0.15 g, 0.344 mmol) in CH2Cl2 (6 mL) was
added 1,4-pentadiene (0.0356 mL, 0.344 mmol). The mixture was
stirred at room temperature for 6 h, the resulting yellow-orange solution
was filtered through Celite, and the filtrate was evaporated to dryness.
Diethyl ether (2 mL) was added to the residue and the resulting solution
was cooled. 5a-syn crystallized as yellow solid which was filtered,
washed with cold Et2O, and air dried (0.01 g, 7% yield).
The same procedure was used in the reaction of [Pd(C6F5)Br-
(NCMe)2] and excess 3-methyl-1,4-pentadiene and the reaction was
monitored by 19F NMR spectroscopy. Column chromatography separa-
tion of the residue containing the reaction mixture afforded compound
9, which was isolated as a colorless oil from the n-hexane eluted
fraction. When Et2O was used as eluent a second batch was obtained
which contained a mixture of the allylic derivatives 5b, 6b, 7b, and
the C6F5-free di(µ-bromo)bis(3-methyl-1-3-η3-pentenyl)dipalladium(II)
(10).
5a-syn: Anal. Calcd for C22H16Br2F10Pd2: C, 31.34; H, 1.91.
Found: C, 31.16; H, 1.93.
The mother liquors were kept at room temperature for 25 days and
the mixture of 5a, 6a, and 7a was separated by preparative TLC using
a silica plate and a hexane:ethylacetate 10:1 mixture as eluent; two
batches were obtained which contained (1) 6a-syn and 7a (Rf ) 0.22)
and (2) 5a-syn, 5a-anti, and 6a-anti (Rf ) 0.17). These mixtures could
not be further separated.
9: 19F NMR (CDCl3, δ, 293 K, 282 MHz), -163.4 (m, Fmeta), -157.7
1
(t, Fpara), -143.1 (m, Fortho); H NMR (CDCl3, δ, 293 K, 300 MHz),
5.76 (m, 2H, J ) 17.2, 10.4, 7.5 Hz, H2 + H4), 5.02 (dt, 2H, J ) 10.4,
1.1 Hz, H1 + H5), 4.97 (dt, 2H, J ) 17.2, 1.1 Hz, H1′ + H5′), 3.00 (m,
1H, J ) 7.5, 7.7 Hz, H3), 2.80 (d, 2H, J ) 7.7 Hz, CH2C6F5). MS(EI)
m/z (relative intensity), 248 (M+, 0.9), 181 (5), 68 (6), 67 (100), 65
(20), 41 (30). HRMS calcd for C12H9F5, m/z 248.0624; found,
248.0629.
The reaction of [Pd(C6F5)Br(NCMe)2] with 3-methyl-1,4-pentadiene
was carried out following the same procedure. 5b-syn was crystallized
from Et2O/n-hexane (10% yield). Anal. Calcd for C24H20Br2F10Pd2:
C, 33.09; H, 2.31. Found: C, 33.06; H, 2.39. Preparative TLC was
performed as described above and afforded (batch 1) 6b-syn, 6b-anti,
and 7b (Rf ) 0.20) and (batch 2) 5b-syn, 5b-anti, and 6b-anti (Rf )
0.14). These mixtures could not be further separated.
10: 1H NMR (CDCl3, δ, 293 K, 300 MHz), 5.11 (dd, 1H, J ) 13,
7.5 Hz, H2), 3.93 (d, 1H, J ) 7.5 Hz, H1-syn), 3.13 (d, 1H, J ) 13 Hz,
H1-anti), 1.68 (m, H4), 1.42 (m, H4′), 1.30 (s, 3H, Me3), 1.14 (t, 3H, J
) 7.6 Hz, Me5).
Synthesis of the Pentafluorophenyl-Substituted Methyl Esters.
Synthesis of Derivatives 12a, 13a, and 14a. 1,4-Pentadiene (0.007
mL, 0.07 mmol) was added to a solution of [Pd(C6F5)Br(NCMe)2]
(0.030 g, 0.07 mmol) in CHCl3 (3 mL) at 243 K. The mixture was
kept at this temperature for 2 h. NaOMe (0.023 g, 0.42 mmol)
suspended in MeOH (3 mL) was added to the mixture and CO was
bubbled through the solution for 20 min. Metallic palladium precipi-
tated which was filtered off and the filtrate was evaporated to dryness.
The residue was chromatographed on a silica column (neutral, 230-
400 mesh) and eluted with Et2O; this operation afforded a mixture of
12a (65%), 13a (20%), and 14a (7%) plus C6F5-COOMe (2%) and
the ester methyl 6-(pentafluorophenyl)-3-hexenoate (6%) derived from
the linear η3-allyl complex 5a. The isolated mixture of esters was
analyzed by GC-MS and NMR spectroscopy.
The reaction of [Pd(C6F5)Br(NCMe)2] with 1,4-pentadiene was
monitored as described above for 3-methyl-1,4-pentadiene. The
temperature was lowered down to 223 K for complete identification
of the less stable compounds. The following complexes were identified:
2a1: 19F NMR (CDCl3, δ, 223 K, 282 MHz), -161.9 (m, Fmeta),
1
-155.9 (t, Fpara), -142.7 (m, Fortho); H NMR (CDCl3, δ, 223 K, 300
MHz), 4.60 (b, 1H, H2), 4.35 (b, 2H, H1 + H1′), 3.10 (H4), 2.60
(CH2C6F5), 1.80 (b, 1H, H3), 0.25 (b, 1H, H3′).
2a2: 19F NMR (CDCl3, δ, 223 K, 282 MHz), -161.9 (m, Fmeta),
1
-155.9 (t, Fpara), -142.7 (m, Fortho); H NMR (CDCl3, δ, 223 K, 300
MHz), 4.90 (b, 2H, H1 + H2), 4.60 (b, 1H, H1′), 3.00-2.80 (3H, H4,
CH2C6F5), 1.10 (b, 1H, H3), 0.80 (b, 1H, H3′).
3a: 19F NMR (CDCl3, δ, 223 K, 282 MHz), -161.0 (m, Fmeta),
1
-156.3 (t, Fpara), -143.2 (m, Fortho); H NMR (CDCl3, δ, 223 K, 300
MHz), 4.90 (b, 2H, H1 + H2), 4.60 (b, 1H, H1′), 3.00-2.80 (3H, H5,
H3, H3′), 2.75, 2.55 (2H, H4, H4′).
12a: 19F NMR (CDCl3, δ, 293 K, 282 MHz), -163.1 (m, Fmeta),
1
-157.2 (t, Fpara), -142.9 (m, Fortho); H NMR (CDCl3, δ, 293 K, 300
4a: 19F NMR (CDCl3, δ, 293 K, 282 MHz), -162.4 (m, Fmeta),
MHz), 5.64 (m, 1H, H4), 4.98 (d, 1H, J ) 11 Hz, H5), 4.93 (d, 1H, J
) 17 Hz, H5′), 3.66 (s, 3H, COOMe), 2.80-2.70 (m, 3H, H3, CH2C6F5),
2.43 (d, 2H, H2, H2′); 13C{1H} NMR (CDCl3, δ, 293 K, 74.5 MHz),
172.0 (C1), 138.5 (C4), 116.8 (C5), 51.7 (COOMe), 40.5 (C3), 39.1 (C2),
27.4 (CH2C6F5). MS(EI) m/z (relative intensity), 294 (M+, 1.2), 181
(45), 74 (70), 71 (100), 59 (47), 41 (21). HRMS calcd for C13H11O2F5,
m/z 294.0679; found, 294.0678.
1
-156.7 (t, Fpara), -143.1 (m, Fortho); H NMR (CDCl3, δ, 293 K, 300
MHz), 6.04 (1H, H2), 4.98 (d, 1H, J ) 15.1 Hz, H1), 4.92 (d, 1H, J )
8.5 Hz, H1′), 3.58 (m, 1H, H5), 3.09 (m), 2.87 (m), (H3 + H3′), 2.40
(m, 1H, H4), 2.10 (m, 1H, H5′).
5a-syn: 19F NMR (CDCl3, δ, 293 K, 282 MHz), -162.7 (m, Fmeta),
1
-157.2 (t, Fpara), -143.9 (m, Fortho); H NMR (CDCl3, δ, 293 K, 300
MHz), 5.23 (m, 1H, J ) 11.2, 6.7 Hz, H2), 4.01 (d, 1H, J ) 6.7 Hz,
H1-syn), 3.84 (m, 1H, J ) 11.8, 8.7, 5 Hz, H3), 2.95 (m, 2H, H5 +
H5′), 2.91 (d, 1H, J ) 11.8 Hz, H1-anti), 2.23 (m, 1H, H4), 2.00 (m,
1H, H4′).
13a: 19F NMR (CDCl3, δ, 293 K, 282 MHz), -162.8 (m, Fmeta),
1
-156.8 (t, Fpara), -143.1 (m, Fortho); H NMR (CDCl3, δ, 293 K, 300
MHz), 5.73 (m, 1H, J ) 17.1, 13.7, 10, 7.1, H4), 5.10 (bd, 1H, J )
17.1, 1.4 Hz, H5′), 5.07 (bd, 1H, J ) 10 Hz, H5), 3.64 (s, 3H, COOMe),
3.00-2.90 (m, 2H, CH2C6F5), 2.80 (m, H2), 2.42 (m, H3), 2.30 (m,
H3′). MS(EI) m/z (relative intensity), 294 (M+, 7), 220 (33), 181 (100),
113 (22), 74 (22), 71 (70), 59 (48), 54 (25). HRMS calcd for
C13H11O2F5, m/z 294.0679; found, 294.0680.
5a-anti: 19F NMR (CDCl3, δ, 293 K, 282 MHz), -162.9 (m, Fmeta),
1
-157.1 (t, Fpara), -144.1 (m, Fortho); H NMR (CDCl3, δ, 293 K, 300
MHz), 5.20 (m, H2), 4.80 (m, 1H, H3), 4.17 (d, 1H, J ) 7 Hz, H1-syn),
3.29 (d, 1H, J ) 13 Hz, H1-anti), 2.80 (m, H5 + H5′), 2.00 (H4), 1.55
(H4′).
14a: 19F NMR (CDCl3, δ, 293 K, 282 MHz), -162.8 (m, Fmeta),
6a-syn: 19F NMR (CDCl3, δ, 293 K, 282 MHz), -161.9 (m, Fmeta),
1
-156.9 (t, Fpara), -142.4 (m, Fortho); H NMR (CDCl3, δ, 293 K, 300
1
-155.7 (t, Fpara), -141.7 (m, Fortho); H NMR (CDCl3, δ, 293 K, 300
MHz), 3.62 (s, 3H, COOMe).
MHz), 5.37 (dd, 1H, J ) 12.8, 7.5 Hz, H2), 4.05 (dd, 1H, J ) 7.5, 1.2
Hz, H1-syn), 3.23 (dd, 1H, J ) 12.8, 1.2 Hz, H1-anti), 3.45 (m), 3.23
(m, J ) 16 Hz, H4 + H4′), 1.20 (s, 3H, Me3).
A mixture of complexes 12b, 13b, and 14b was obtained by mixing
3-methyl-1,4-pentadiene (0.028 mL, 0.23 mmol) and [Pd(C6F5)-
Br(NCMe)2] (0.100 g, 0.23 mmol) in CH2Cl2 (5 mL) at 253 K and
letting it stand at this temperature for 1 h; carbonylation of this mixture
as described above gave a mixture of the ester derivatives: 12b (55%),
13b (24%) (each of them as a 1:1 diastereomeric mixture), 14b, (5%)
plus C6F5-COOMe (7%) and several unidentified compounds (9% total,
each one less than 4%). The isolated mixture of esters was analyzed
by GC-MS and NMR.
6a-anti: 19F NMR (CDCl3, δ, 293 K, 282 MHz), -162.1 (m, Fmeta),
1
-156.0 (t, Fpara), -140.8 (m, Fortho); H NMR (CDCl3, δ, 293 K, 300
MHz), 5.14 (dd, 1H, J ) 13, 7.5 Hz, H2), 4.11 (dd, 1H, J ) 7.5, 1.6
Hz, H1-syn), 3.46 (dd, 1H, J ) 13, 1.6 Hz, H1-anti), 3.06 (m), 2.80 (m,
2H, J ) 14.5 Hz, H4 + H4′), 1.51 (s, 3H, Me3).
7a: 19F NMR (CDCl3, δ, 293 K, 282 MHz), -162.5 (m, Fmeta),
1
-157.0 (t, Fpara), -143.0 (m, Fortho); H NMR (CDCl3, δ, 293 K, 300
12b1: 19F NMR (CDCl3, δ, 293 K, 282 MHz), -163.5 (m, Fmeta),
-157.67 (t, Fpara), -143.1 (m, Fortho); 1H NMR (CDCl3, δ, 293 K, 300
MHz), 5.64 (m, 1H, H4), 4.95 (dd, 1H, J ) 10.2, 1.6 Hz, H5), 4.80
MHz), 5.52 (m, 1H, J ) 11.5, 7 Hz, H2), 4.08 (d, 1H, J ) 7 Hz, H1-
syn), 4.10 (m, H3), 3.70 (m, 1H, H4), 2.97 (d, 1H, J ) 11.5 Hz, H1-
anti), 1.54 (d, 3H, J ) 7.2 Hz, Me4).